Sigyn Therapeutics, Inc.
SIGY
$4.15
$0.153.75%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 3.42% | 155.11% | 127.12% | -89.82% | 39.29% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | 0.00% | 0.00% | 0.00% | 0.00% |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -83.87% | 0.00% | -22.64% | 28.36% | 373.95% |
| Total Current Assets | -82.05% | 59.33% | 13.66% | -67.42% | 67.99% |
|
|
|||||
| Total Current Assets | -82.05% | 59.33% | 13.66% | -67.42% | 67.99% |
| Net Property, Plant & Equipment | -33.44% | -30.36% | -27.78% | -25.58% | -23.69% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 241.55% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Assets | -33.59% | 10.38% | -11.50% | -51.04% | -3.33% |
|
|
|||||
| Total Accounts Payable | 31.80% | 69.14% | 43.69% | 99.74% | 40.95% |
| Total Accrued Expenses | 136.04% | 334.75% | 701.07% | 2,522.14% | 2,530.56% |
| Short-term Debt | -9.80% | -38.71% | -30.44% | 3.67% | 39.93% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 14.40% | 14.55% | 14.74% | 14.70% | 14.85% |
| Total Finance Division Other Current Liabilities | -46.88% | -100.00% | -4.35% | 160.00% | 166.67% |
| Total Other Current Liabilities | -46.88% | -100.00% | -4.35% | 160.00% | 166.67% |
| Total Current Liabilities | 27.91% | 11.90% | 20.14% | 49.46% | 76.11% |
|
|
|||||
| Total Current Liabilities | 27.91% | 11.90% | 20.14% | 49.46% | 76.11% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -9.80% | -38.71% | -30.44% | 3.67% | 39.93% |
| Capital Leases | -55.34% | -47.54% | -41.37% | -36.53% | -32.60% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 25.09% | 9.77% | 17.28% | 44.50% | 67.00% |
|
|
|||||
| Common Stock & APIC | 28.95% | 55.34% | 49.41% | 30.49% | 49.82% |
| Retained Earnings | -29.45% | -39.28% | -39.98% | -41.74% | -57.62% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -30.63% | -9.70% | -20.71% | -71.41% | -79.30% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -30.63% | -9.70% | -20.71% | -71.41% | -79.30% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -30.63% | -9.70% | -20.71% | -71.41% | -79.30% |
|
|
|||||